ADAGRASIB vs ADALIMUMAB-ADBM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ADAGRASIB vs ADALIMUMAB-ADBM: Safety Overview
| Metric | ADAGRASIB | ADALIMUMAB-ADBM |
|---|---|---|
| Total FAERS Reports | 899 | 106 |
| Deaths Reported | 315 | 1 |
| Death Rate | 35.0% | 0.9% |
| Hospitalizations | 350 | 15 |
| Average Patient Age | 68.3 yrs | 57.7 yrs |
| % Female Patients | 56.4% | 68.3% |
| FDA Approval Date | Dec 12, 2022 | N/A |
| Manufacturer | Mirati Therapeutics, Inc | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Route | ORAL | N/A |
| Marketing Status | Prescription | Prescription |